BackTalis Biomedical Overview

Talis Biomedical Receivables

Track Talis Biomedical's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-532000.00 vs prior year quarter

Peer average

Loading

Talis Biomedical Receivables History

Loading

Talis Biomedical vs. peers: Receivables Comparison

Loading

Talis Biomedical Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Talis Biomedical (TLIS) FAQ

Talis Biomedical (TLIS) currently reports a receivables of $0 as of June 2024. That compares with $530K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Talis Biomedical's receivables history and peer comparisons.

Talis Biomedical's receivables decreased from $530K to $0 — a 100.0% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Talis Biomedical reported $0 in receivables as of June 2024. That compares with $530K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Talis Biomedical, and consider following TLIS for alerts when major investors trade the stock.

Talis Biomedical is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TLIS with unrelated industries.